The evolutionary conserved protein Cdc48/VCP is involved in various cellular processes, such as protein degradation, membrane fusion and chaperone activity. Increased levels of Cdc48/VCP correlate with cancer, whereas Cdc48/VCP at endogenous levels has been proposed to be a pathological effector in protein deposition diseases. Upon mutation Cdc48/VCP triggers the multisystem disorder 'inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia' (IBMPFD). The roles of Cdc48/VCP under these diverse pathological conditions, especially its function in decreased and increased incidences of cell death underlying these diseases, are poorly understood. Mutation of yeast CDC48 (cdc48 S565G ) results in yeast cells demonstrating morphological markers of apoptotic cell death. In other species it has been confirmed that mutations and depletion of Cdc48/VCP cause apoptosis, whereas increased levels of this protein provide an anti-apoptotic effect. This review critically compares mechanisms of Cdc48/VCP-mediated apoptosis observed in yeast and other species. Cdc48/VCP plays a triple role in cell death. At first, loss-of-function of Cdc48/VCP due to mutation or depletion causes ER stress and oxidative stress, triggering apoptosis. Secondly, upon exogenously applied ER stress functional Cdc48/VCP is important in the processing of caspases and plays therewith a pro-apoptotic role. Finally, Cdc48/VCP protects cells from apoptosis through mediating and activating pro-survival signaling pathways, namely Akt and NFκB signaling. This complex role in cell death pathways could correspond with the various pathophysiological conditions Cdc48/VCP is involved in.
Introduction
The yeast cell division cycle protein 48 (Cdc48p) and its highly conserved mammalian orthologue valosin-containing protein (VCP/p97) are ubiquitously expressed members of the AAA-ATPase family (ATPases associated with various cellular activities) [1] [2] [3] [4] . Cdc48/VCP is made up of four domains: the N-terminal domain, the ATPase domains D1 and D2, and the C-terminal domain [5] (Fig. 1) . The N-terminal domain binds to cofactors, such as Ufd1 (ubiquitin-fusion degradation protein 1) and p47 [6] , and to ubiquitinated substrates [5, 7] . The D1 domain mediates the oligomerization of Cdc48/VCP [5, 8] , and the major ATPase activity of Cdc48/VCP has been assigned to the D2 domain [5, 8] . The C-terminal domain of Cdc48/VCP binds cofactors, such as the multiubiquitination enzyme Ufd2 [9, 10] , and is involved in the phosphorylationdependent nuclear localization of yeast Cdc48p [11] .
Similar to other AAA-ATPases, Cdc48/VCP assembles into a stable homohexameric barrel structure with a small central channel [12] [13] [14] [15] [16] . The homohexamer undergoes drastic conformational changes during its nucleotide hydrolysis cycle presumably generating the mechanical force to dissociate large protein complexes [15, [17] [18] [19] . Cdc48/VCP specifically removes ubiquitinated protein substrates from protein complexes or other cellular structures, such as the ER membrane [7] . Applying this general paradigm, Cdc48/VCP is crucially involved in several cellular functions controlled by ubiquitination [7] . It is engaged in the proteasomal degradation of proteins, in the degradation of ER luminal and membrane proteins in the ER-associated degradation pathway (ERAD), in membrane fusion, in transcriptional and cell cycle control, in chaperonelike processing of protein aggregates, and in DNA repair (for reviews: [5, 7, [20] [21] [22] [23] [24] [25] ).
Mutations in human VCP trigger the human multisystem disorder 'inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia' (IBMPFD) [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . This disorder is characterized by inclusion bodies in muscle or brain [31, 34, 35] . Most patients suffer from a strong myopathy that may be associated with bone disease and/or frontotemporal dementia [31, 34] . Wild-type VCP co-localizes with protein depositions characteristic for various neurodegenerative disorders, such as polyglutamine, Parkinson's and Alzheimer's diseases [36] [37] [38] . Therefore, VCP has been proposed to be a sensor for aggregated proteins causative for these disorders [37, 39] . In a Caenorhabditis elegans model for polyglutamine diseases Cdc48/VCP has been shown to disintegrate protein depositions formed by proteins with expanded polyglutamine stretches [40] , and in mammalian cells VCP is involved in both the formation and clearance of aberrant protein depositions [39, 41] . In contrast, elevated levels of VCP correlate with increased incidences of metastasis in various types of cancer [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] . The underlying prosurvival effect of elevated VCP levels and the role of Cdc48/VCP in pathophysiological conditions associated with increased incidences of cell death promoted the analysis of molecular details of Cdc48/VCP in cell survival and cell death pathways.
Expression of a mutant form of yeast Cdc48p (Cdc48p-S565G) resulted in yeast cells demonstrating morphological markers of apoptotic cell death, previously known only from multicellular organisms [56] . This finding initiated the detailed analysis of programmed cell death in yeast and established yeast as an important model for apoptosis research (for review: [57] [58] [59] [60] [61] [62] [63] [64] [65] ). According to the events in yeast expressing mutated CDC48 (cdc48 S565G ), mutation and depletion of Cdc48/VCP in other species lead to cell death with apoptotic features [66] [67] [68] [69] . Thus, apoptosis due to Cdc48/VCP dysfunction is evolutionary highly conserved. This striking coincidence points to yeast as a suitable model organism for the analysis of Cdc48/VCPmediated cellular processes with potential relevance for human pathophysiological conditions. This review aims at describing and comparing mechanisms of Cdc48/VCP-mediated apoptosis in yeast and other species, especially mammalian cells. Emphasis is laid on relating the data of Cdc48/VCP-dependent cell death with respect to VCPmediated human disorders.
Apoptotic mechanisms in yeast cells expressing mutated
2.1. Morphological markers of apoptosis in yeast expressing a specific mutation of CDC48 (cdc48 S565G )
Cdc48p was the first apoptotic mediator found in S. cerevisiae [56] . Replacement of a conserved serine residue in the second ATPase domain (D2) of yeast CDC48 (serine 565 to glycine, S565G, see Fig. 1 ) resulted in yeast cells with increased susceptibility to undergo cell death [56, 70] . Cell death could be triggered very efficiently by heat shock (37°C), growth to late exponential or stationary phases, ageing and radiation [56, 71, 72] . The dying cells demonstrated morphological markers of apoptosis: (i) nuclear fragmentation, (ii) chromatin condensation and fragmentation, (iii) DNA fragmentation, (iv) cytoplasmic vacuolization, (v) abnormally shaped cells, and (vi) translocation of the phospholipid phosphatidylserine from the inner to the outer leaflet of the plasma membrane [56] . Inhibition of protein synthesis applying the specific ribosome inhibitor cycloheximide prevented the emergence of these apoptotic features [71] . Since gene expression and protein synthesis are necessary for completing "programmed" cell death scenarios, these data demonstrated that yeast cells expressing mutated CDC48 (cdc48 S565G ) undergo programmed cell death with typical markers of apoptosis.
Apoptotic features are not a general phenomenon for all known CDC48 mutations but appear to be rather specific for the cdc48 S565G allele. Other CDC48 alleles, such as the temperaturesensitive allele cdc48-3 ts that triggers cell cycle arrest upon elevated temperatures, lack morphological markers of apoptotic cell death [56, 71] . Therefore, the cdc48 S565G mutation might affect a specific cellular function that triggers apoptosis. The amino acid exchange is localized in the highly conserved D2 domain that is responsible for the major ATPase activity of Cdc48p (see Fig. 1 ), indicating that ATPase-deficiency of Cdc48p-S565G may be important for apoptotic cell death.
Crucial role of reactive oxygen species (ROS) and mitochondria during cell death in cdc48 yeast
The analysis of the molecular mechanisms underlying apoptotic cell death in yeast cells expressing mutated CDC48 (cdc48 S565G ) resulted in the finding that ROS are involved in cell death [71] . Marked accumulation of ROS could be detected in apoptotic yeast cells expressing mutated CDC48 by staining the cells with dihydrorhodamine 123 or dihydroethidium that are oxidized by ROS to fluorescent rhodamine and ethidium, respectively [71] . Depletion of ROS upon addition of radical scavengers to the growth media or due to growth of yeast cells in an oxygen-free environment inhibited the accumulation of ROS and prevented cells to undergo apoptosis even under stress conditions (e.g., heat shock) [71] . These data demonstrate that ROS play a pivotal role and are not a by-product in apoptotic cell death in cells expressing mutated CDC48 (cdc48 S565G ). Both exogenously applied oxidative stress through treatment with low doses of hydrogen peroxide and endogenously produced ROS, e.g., upon heterologous expression of the mammalian pro-apoptotic factor Bax or upon treatment with the yeast mating-type pheromone, trigger apoptotic cell death in yeast [71, 73, 74] . Cells exposed to acidic stress and ageing yeast cells can be removed from the yeast population via ROS-dependent apoptosis [75] [76] [77] [78] . Thus, the crucial role of ROS in cells expressing mutated CDC48 (cdc48 S565G ) is in line with several apoptosis pathways in yeast (for review: [57, 58, 61] ).
Endogenously produced ROS in yeast may be of cytoplasmic or mitochondrial origin [79, 80] . Deregulated peroxisomal enzymes or a misregulated ER-resident oxidative protein folding machinery has been reported to result in the cytoplasmic production of ROS [79, 80] . A major burst of cellular ROS results from the deregulation of the respiratory chain in the inner mitochondrial membrane [81] . Applying a differential plating assay, we could show that yeast cells expressing mutated CDC48 (cdc48 S565G ) grown under apoptotic conditions were unable to proliferate on lactate as obligatory respiratory carbon source [82] . These data hint to a decreased respiratory capacity of these cells and point to a deregulation of the respiratory chain. The use of specific inhibitors of the cytochrome bc 1 complex of the respiratory chain significantly reduced the number of yeast cells accumulating ROS [82] . Thus, deregulation of the respiratory chain is one major cause for the emergence of ROS and therewith for apoptotic cell death in cells expressing mutated CDC48 (cdc48 S565G ). A crucial mitochondrial role in cell death was confirmed by generating CDC48 ρ 0 and cdc48 S565G ρ 0 strains [82] . In these yeast strains mitochondrial DNA was depleted during growth on media containing low amounts of ethidium bromide, resulting in yeast cells lacking functional mitochondria [83] . Under apoptotic conditions, cdc48 S565G ρ 0 cells were unable to accumulate ROS [82] . As evidenced by a survival plating assay, the cell viability of cdc48 S565G ρ 0 cells was increased when compared to cdc48 S565G ρ + cells [82] . Thus, mitochondria play a detrimental role in CDC48-mediated apoptosis in yeast through production of deathcausing ROS.
A pro-apoptotic role of mitochondria has been shown in several studies dealing with programmed cell death in yeast (for review: [61] ). Ludovico and colleagues demonstrated that loss of mitochondrial membrane potential upon treatment of yeast cells with low doses of acetic acid was correlated with the accumulation of ROS and apoptotic cell death [77] . A causative role of mitochondria in cell death was further established with cells lacking mitochondrial DNA (ρ 0 strains) or cells defective in an essential component of the mitochondrial ATP synthase complex (ATP10) [77] . In both, and in contrast to wild-type cells, acetic acid-triggered apoptosis did not occur [77] . In another study dealing with apoptotic cell death in yeast upon treatment with elevated levels of yeast pheromone, a burst of ROS produced by the mitochondrial cytochrome bc 1 complex of the respiratory chain was demonstrated, resulting in cell death [84] . These authors further proposed a sequence of events that resulted in mitochondria-mediated apoptotic cell death, where pheromone treatment lead to elevated levels of cytosolic Ca 2+ ions [61, 84] . These cations triggered an increase in the respiratory rate and in the energy coupling within the respiratory chain. The consequent hyperpolarization of mitochondria resulted in the accumulation of mitochondrially produced ROS and in the fragmentation of the mitochondrial network within the cell concomitant to the depolarization of mitochondria [84] . Mitochondrial enlargement, which might be a result of such a hyper-and depolarization of mitochondria, was also observed in apoptotic yeast cells expressing mutated CDC48 (cdc48 S565G ) [82] . Therefore, increased respiratory rate and the consequent hyperpolarization might also precede the accumulation of death-causing ROS in apoptotic cdc48 S565G cells. However, how such cellular events result in yeast, like in mammalian cells, in the permeabilization of the inner mitochondrial membrane and in mitochondrial rupture is still a matter of debate [61, [85] [86] [87] [88] [89] .
Beside the production of ROS, mitochondria play a more complex role during apoptosis. Cells expressing mutated CDC48 released cytochrome c into the cytosol and showed emergence of caspase-like enzymatic activity [82] . Cytochrome c mutant yeast strains demonstrated decreased apoptosis under hyperosmotic stress conditions compared to wild-type strains [90] . Disruption of cytochrome c resulted in delayed cell death in yeast pheromone-induced apoptosis without affecting ROS production [74, 84] . This indicates that cytochrome c may play a pivotal pro-apoptotic role during execution of apoptosis [74, 84] and could therefore be an important factor during cell death triggered by CDC48 mutation (cdc48 S565G ). A differential proteomic analysis applying two-dimensional gel electrophoresis (2-DE) revealed 32 significant protein spot alterations at the mitochondrial proteome level in apoptotic cells expressing mutated CDC48 (cdc48 S565G ) [82] . Among the observed altered proteins are further promising candidates for regulating CDC48-mediated mitochondria-dependent apoptosis:
(i) Accumulation of the yeast orthologue of the human 'translationally controlled tumor protein' (TCTP) was demonstrated in mitochondrial extracts of the cdc48 S565G mutant strain under apoptotic conditions. Human TCTP was proposed to be a modulator of apoptotic cell death in mammalian cells [91, 92] . Yeast TCTP, like human TCTP, is a microtubule-binding cytoplasmic protein [93, 94] . Yeast TCTP translocated to mitochondria upon mild oxidative stress or replicative ageing of yeast cells [93] that is known to be associated with the accumulation of ROS [76] . Therefore, this yeast protein was termed 'microtubule and mitochondria interacting protein 1′ (Mmi1p) [93] . Deletion of the MMI1 gene resulted in yeast cells with markedly increased resistance to oxidative stress and increased lifespan of individual yeast cells [93] . Thus, Mmi1p may play an important role in oxidative stress-dependent apoptosis in yeast. Enrichment of Mmi1p in mitochondrial extracts of cdc48 S565G cells, which accumulated ROS predominantly produced by mitochondria, suggests a role of this protein in mitochondria-mediated cell death in the cdc48 S565G strain. (ii) Depletion of mitochondrial cyclophilin C (Cpr3p) in mitochondrial extracts of apoptotic cdc48 S565G yeast cells was found. Very recently, Cpr3p was identified in a genetic screen for mediators of Cu-induced apoptotic cell death in yeast [95] . Here, the deletion of Cpr3p abrogated Cu-induced apoptosis but did not interfere with ROS production [95] . In contrast, lack of Cpr3p had no effect on acetic acid-induced apoptosis in yeast [88, 89] . If the observed depletion of Cpr3p in mitochondrial extracts of cdc48 S565G cells is an attempt of the cells to escape cell death or if Cpr3p depletion is itself pro-apoptotic under these conditions remains for further investigations. The mammalian homologue cyclophilin D is an important regulator of mitochondriamediated apoptosis in mammalian cells [96] [97] [98] . It is involved in the opening of the inner mitochondrial membrane [96] . Despite intensive efforts, the exact role of cyclophilin D in these processes is poorly understood and remains highly controversial [97, 98] . Therefore, the detailed analysis of the role of Cpr3p during yeast cell death is of high interest for the elucidation of apoptotic mechanisms in both yeast and mammalian cells. (iii) Two components of the actin cytoskeleton were found to be accumulated in mitochondrial extracts in cdc48 S565G cells. A connection between yeast apoptosis and actin dynamics has been established [99, 100] . These authors demonstrated that decreased actin dynamics caused depolarization of the mitochondrial membrane and an increase in ROS production resulting in cell death. Thus, the observed mitochondrial damage and ROS production in the cdc48 S565G strain concomitant to the accumulation of proteins of the actin cytoskeleton in mitochondrial extracts hint to an altered dynamic of the actin cytoskeleton in apoptotic cdc48 S565G cells. (iv) Elevated amounts of mitochondrial ribosomal subunits were observed. A transcriptome analysis of apoptotic cdc48 S565G cells revealed upregulation of several components of the mitochondrial protein translation machinery [101] . These data therefore point to active protein alterations in mitochondria during the cell death program.
Yeast cells expressing mutant CDC48 (cdc48 S565G ) demonstrated emergence of caspase-like activity. Yeast caspase-1 (YCA1) is a molecular regulator within several apoptotic scenarios in yeast [75, [102] [103] [104] . Disruption of YCA1 completely abrogated hydrogen peroxide-induced apoptosis [102] . Therefore, the observed emergence of caspase-like enzymatic activity in cdc48 S565G cells hint to a role of YCA1 during the apoptotic process.
In summary, a specific mutation in CDC48 (cdc48 S565G ) results in yeast cells showing typical markers of apoptosis. ROS play an essential role during cell death. Mitochondria are pivotal for the progression of programmed cell death. They produce the detrimental ROS, show mitochondrial enlargement and loss of respiratory capacity, they release cytochrome c into the cytosol, and demonstrate distinct alterations at the proteome level. These altered proteins should be analyzed in the future, in order to elucidate distinct molecular mechanisms of ROS-and mitochondria-dependent apoptosis typically for cells expressing mutated CDC48 (cdc48 S565G ) in comparison to other known yeast apoptotic pathways.
Dysfunction of mutated CDC48 (cdc48 S565G ) affects mitochondria by increased levels of polyubiquitination
Expression of mutated CDC48 (cdc48 S565G ) results in yeast cells with increased susceptibility to undergo ROS-and mitochondria-dependent apoptotic cell death. However, to date no specific role of Cdc48p is known with respect to the cellular balance of oxidative stress or mitochondrial functionality. Therefore, it remains puzzling why a specific mutation in CDC48 affects mitochondria and triggers apoptosis. Cdc48p and its mammalian orthologue VCP are involved in many different cellular processes mostly controlled by ubiquitination, such as protein degradation of ER proteins (ERAD), cell cycle control and membrane fusion [20] [21] [22] [23] [24] [25] . Apoptotic cdc48 S565G cells do not arrest during cell cycle, whereas yeast cells expressing CDC48 alleles resulting in cell cycle arrest, such as cdc48-3 ts , do not show typical markers of apoptotic cell death [5, 7, 56] . Thus, the high susceptibility to undergo apoptosis is probably not due to a dysfunction of mutated CDC48 (cdc48 S565G ) in cell cycle control. In contrast, EM analysis of apoptotic cdc48 S565G cells revealed an expansion of the ER [56] , hinting to a defect of Cdc48p-S565G in one of its ER-related cellular functions, namely homotypic ER fusion and ubiquitin-dependent degradation of ER luminal and membrane proteins in ERAD. Recently, we demonstrated that cells expressing mutated CDC48 (cdc48-S565G ) showed markedly increased levels of polyubiquitinated proteins in total cell lysates [105] . These polyubiquitinated proteins co-purified with membranous (e.g., ER-derived microsomes) but not cytosolic fractions [105] . Since Cdc48p-S565G showed a decreased activity in degrading a misfolded ER luminal model substrate compared to wild-type Cdc48p [106] , these data hint to a dysfunction of Cdc48p-S565G in its role in ERAD (Fig. 2, no. 1, 2) . Surprisingly, we observed a strong accumulation of Cdc48p-S565G, polyubiquitinated proteins and a number of ER-associated proteins in mitochondrial fractions obtained by differential centrifugation [82, 105] . This co-purification of Cdc48p-S565G and polyubiquitinated proteins with mitochondria was very stable, since it persisted further mitochondrial purification applying sucrose-gradient centrifugation [105] . We further anlyzed these mitochondria, applying zone electrophoresis in a free-flow device (ZE-FFE) that separates organelles according to their surface charges and hydrodynamic properties in a continuous buffer flow upon an electric field [105, 107] . We found that the majority of mitochondria in apoptotic cdc48 S565G cells did not show an altered deflection in the ZE-FFE separation chamber compared to CDC48 wild-type and were unaffected by Cdc48p-S565G and polyubiquitination [105] . In contrast, a small part of the mitochondria was found to strongly associate with ER-derived microsomes [105, 108] . In apoptotic cdc48-S565G cells this fraction was markedly increased compared to CDC48 wild-type and contained drastically increased levels of Cdc48p-S565G, polyubiquitinated proteins and ER-derived microsomes [105] . Ultrastructural analysis of yeast cells revealed that the ER demonstrated an increased spatial proximity to mitochondrial membranes in cdc48 S565G cells (own unpublished data). These data suggest a crucial link between ERAD dysfunction upon mutation of CDC48 (cdc48-S565G ) and mitochondria. In this model polyubiquitinated proteins accumulate in/at the ER. The resulting ER stress triggers ER expansion. The possible concomitant attachment to nearby mitochondria may result in the transfer of ERassociated deleterious processes to mitochondrial membranes (Fig. 2, no. 3).
First, the stress exerted on mitochondrial membranes may be of physical nature. An expanding ER might apply forces to or strengthen the interaction with the mitochondrial reticulum, resulting in damaged mitochondrial membranes. Second, ER stress might lead to impairment of the turnover of mitochondrial membranes affecting membrane integrity. Phospholipids are synthesized within the ER and are then transported in a ubiquitin-regulated fashion to mitochondria to renew the mitochondrial membranes [109] [110] [111] . Cdc48p is involved in ubiquitin-mediated ER membrane fusion processes [7, 112] . Thus, CDC48 mutation might specifically affect membrane transport from the ER to mitochondria. Third, ROS produced in the ER under ER stress may damage nearby mitochondrial membranes. In an ERAD-deficient yeast model, overexpression of misfolded proteins leads to ER stress and apoptosis [113] . Here, overload of the ER-resident oxidative ), have a high susceptibility to undergo apoptosis. Cdc48p-S565G shows decreased activity, especially in ERAD (no. 1). This results in the accumulation of polyubiquitinated proteins at microsomes, in ER stress and ER expansion (no. 2). Aberrant association of polyubiquitinated microsomes to mitochondria might cause damage of mitochondrial membranes leading to a crucial mitochondrial impairment (no. 3). Alternatively, CDC48 dysfunction might affect mitochondrial function directly (no. 4), although a mitochondrial function of Cdc48p is currently unknown. The impaired mitochondria produce a burst of ROS (no. 5), triggering caspase activity that ultimately results in apoptotic cell death (no. 8). ER-derived ROS may contribute to the mitochondrially produced oxidative stress (no. 6) and may enforce mitochondrial impairment (no. 7).
protein folding machinery lead to the accumulation of ERderived ROS [113] . Since the cdc48 S565G strain is characterized by dysfunctional ERAD [105, 106] , this raises the question whether potential ER-derived ROS in cdc48 S565G cells damage nearby mitochondrial membranes (Fig. 2 , no. 6 and 7). In either scenario, damaged mitochondrial membranes could lead to the release of cytochrome c into the cytosol, to the loss of mitochondrial functionality and to a drastically increased mitochondrial production of ROS (Fig.  2, no. 5 ). According to previous results obtained in other apoptotic yeast strains, accumulation of ROS could mediate the induction of caspase-like enzymatic activity [102] , resulting in events that initiate DNA fragmentation and apoptotic cell death (Fig. 2, no. 8) .
Future studies will have to address the mechanisms of Cdc48p-S565G-mediated mitochondrial damage (Fig. 2, no. 3,  4 ). Of special interests are the elucidation of ERAD and ER stress components that mediate or mimic upon mutation the specific pro-apoptotic effect of Cdc48p-S565G. In a previous study, Haynes and colleagues discovered ERV29 as a gene essential for the elimination of misfolded proteins form the ER [113] . Challenging ERAD by overexpressing the misfolded model ERAD substrate CPY ⁎ (mutated carboxypeptidase Y) in an erv29Δ strain resulted in persistent ER stress and in the subsequent induction of the unfolded protein response that triggered ER-derived ROS and mitochondria-dependent apoptotic cell death in yeast [113] . These authors could show that the unfolded protein response components IRE1 and HAC1 were critical for the production of ROS and for triggering cell death [113] . It is tempting to speculate that the ERAD gene ERV29 and the ER stress/unfolded protein response genes IRE1 and HAC1 may also play a role in mediating the pro-apoptotic stimulus of Cdc48p-S565G. Beside the evaluation of ERAD and ER stress genes in apoptosis, the systematic analysis of different CDC48 mutations (e.g., non-apoptotic alleles vs. proapoptotic cdc48 S565G ) may further enable a better understanding how dysfunction of CDC48-mediated cellular processes trigger apoptotic cell death.
Cdc48/VCP-mediated apoptosis in other species

Mammalian cells
A role of mammalian VCP in apoptosis became evident from a study of Shirogane and colleagues [68] . Applying a cDNA extraction approach, these authors searched for target genes that are specifically expressed in stimulated murine cells expressing the cytoplasmic serine/threonine kinase Pim-1, a protein involved in gp130/STAT3-mediated cell survival and cell proliferation [68] . They found VCP to be strongly induced upon expression of Pim-1 [68] . VCP was assigned to have anti-apoptotic functions, since overexpression of VCP was able to partially replace Pim-1 in its role in promoting cell survival [68] . In contrast, expression of mutant VCP with critical mutations in the conserved ATP binding sites of both ATPase domains (D1 and D2; lysine to alanine substitutions: K251/524A, see Fig. 1 ) resulted in a drastic decrease in cell proliferation and massive induction of apoptotic cell death, as evidenced by the emergence of DNA fragmentation [68] . This mutant VCP strongly inhibited gp130/STAT3-mediated cell proliferation and suppressed the expression of the antiapoptotic protein Bcl-2 [68] . Thus, Pim-1 may induce VCP expression, in order to mediate gp130/STAT3-mediated cell proliferation and cell survival [68] . This initial study on the role of mammalian VCP in apoptosis demonstrated for the first time that increased levels of wild-type VCP have an antiapoptotic effect, whereas expression of mutant VCP triggers cell death with apoptotic features. Since then several studies aimed at elucidating the role of VCP activity on cell survival and cell death.
Mutation and oxidative modification of VCP promote apoptosis
The pro-apoptotic role of VCP harboring mutations in its ATPase domains was confirmed in other studies [36, 114] . These authors generated a series of VCP mutations, expressed them in neuronally differentiated PC12 (rat pheochromocytoma) cells, and evaluated the cells for morphological alterations and the induction of cell death [36] . They revealed that the second ATPase domain of VCP (D2) is critical for cell survival (see Fig. 1 ). Deletion of the D2 domain, mutation of the conserved ATP binding (lysine 524 to alanine, K524A) or ATPase active site (glutamate 578 to glutamine, E578Q) of this domain resulted in pro-apoptotic VCP variants, with the deletion mutant and VCP-K524A showing the strongest effects [36] . In contrast, expression of critical mutations in the first ATPase domain (D1) had no severe effects on cell viability [36] . The ATPase activity of recombinantly expressed VCP-K524A was strongly reduced when compared to wild-type VCP [114] . Since the D2 domain of VCP is responsible for the major ATPase activity [5] , the detrimental effect of D2 mutations on cell survival is very likely due to loss of the ATPase activity of VCP.
Cells expressing ATPase-deficient VCP-K524A are characterized by strong vacuolization followed by cell death [36, 115] . Ultrastructure analysis revealed that the membranes of the emerging vacuoles bound ribosomes [36] . From the known roles of VCP in ER-related functions (ER membrane fusion and ERAD), the authors suggested that this abnormal vacuoles originated from the ER upon dysfunction of VCP [36] . Indeed, the cytoplasmic vacuoles could be stained with an ER marker, and the significantly increased expression of BiP/ GRP78 mRNA and CHOP protein, two ER stress markers, hinted to the induction of ER stress [114] . Accumulation of polyubiquitinated proteins in membrane fractions but not in cytosolic fractions, as well as decreased degradation of the ERAD substrate mutant CFTR demonstrated dysfunction of the ATPase-deficient VCP in its role in ERAD [114] . The observed apoptotic cell death in cells expressing ATPase-deficient VCP-K524A is thus accompanied with ERAD dysfunction, the induction of ER stress and abnormal ER expansion [114] (Fig.  3A, no. 1, 2) . These data suggest that VCP mutations in the second ATPase domain (D2) trigger cell death via an ER stressmediated apoptotic pathway.
Interestingly, the ATPase activity of mammalian VCP, but not of yeast Cdc48p, can be negatively modulated by oxidative stress [116] . Applying oxidative stress (e.g., via low doses of hydrogen peroxide) resulted in decreased ATPase activity of VCP. This effect could be reversed by treatment with reducing agents, such as DTT [116] . The authors of this study revealed that the decreased ATPase activity upon oxidative stress was due to oxidative modification of distinct cysteine residues within VCP [116] . One of these residues, cysteine 522, a residue conserved in metazoan organisms but not in protozoans like yeast, was found to be especially important in the regulation of the ATPase activity of VCP [116] . Replacement of cysteine 522 with the similar residue threonine, which cannot be oxidized, resulted in a VCP variant (VCP-C522T) that demonstrated an oxidative stress-resistant ATPase activity [116] . In contrast, replacement of cysteine 522 with the residue lysine mimicking the oxidated state of cysteine (VCP-C522K) resulted in decreased VCP-ATPase activity, in aberrant ER expansion, in the induction of ER stress and cell death, highly similar to the expression of ATPase-deficient VCP-K524A [116] . Therefore, the decrease in the ATPase activity of endogenous VCP upon oxidative stress affects the functionality of the ERAD pathway triggering ER stress-mediated cell death [116] (Fig. 3A, no. 1, 2 , 6) . It is thus possible that in mammalian cells an additional level of regulation occurs, where oxidative stress amplifies ERAD dysfunction and ER stress through oxidative modification of VCP (Fig. 3A, no. 5 ).
VCP depletion may have both pro-and anti-apoptotic effects
Loss of ATPase activity of VCP through mutation or oxidative modification results in ERAD dysfunction, ER stress and apoptotic cell death [36, 68, 114, 116] . Depletion of VCP should also result in decreased cellular activity of VCP and should have consequently similar detrimental effects on cell survival (Fig. 3A) . In fact, applying an RNA interference (RNAi) approach in human HeLa cells, Wojcik and colleagues demonstrated that depletion of VCP affected ubiquitin-dependent protein degradation, leading to the cellular accumulation of polyubiquitinated proteins [117] . The observed dispersed aggregates of polyubiquitinated proteins upon RNAi of VCP and the inhibition of aggresome formation, i.e., large centrosomal cellular aggregates, further hinted to a VCP-related dysfunction of the ubiquitin- proteasome system [117] . When reducing cellular VCP amounts, a considerable cytoplasmic vacuolization was found [117] , as observed in cells expressing ATPase-deficient VCP. Analysis of these vacuoles with fluorescence and electron microscopy confirmed that these vacuoles origin from an aberrant expansion of the ER [117, 118] . As observed in cells with decreased VCP-ATPase activity, RNAi of VCP resulted in reduced cell proliferation and triggered apoptotic cell death [117] . Induction of the pro-apoptotic factor p53 and cleavage of the caspase substrate PARP was correlated with the emergence of caspase-3/7 activity [117] . Therefore, depletion of VCP has highly similar effects on cells like the expression of ATPase-deficient variants of VCP: ERAD dysfunction, ER expansion, and ER stress that are causing or correlated with apoptotic cell death (Fig. 3A) . Wojcik and colleagues observed that a marked number of VCP-depleted cells demonstrated mitotic abnormalities due to the lack of mitotic progression beyond pro-metaphase/metaphase [117] . Such an effect on cell cycle progression was not described in mammalian cells expressing ATPase-deficient VCP [36, 114] . Thus, although depletion of VCP applying RNAi and expression of ATPase-deficient VCP have very similar effects on cellular function, the loss of VCP activity upon both methods is not perfectly equivalent. An explanation could be that the various VCP-related cellular functions, such as ERAD and cell cycle control, respond differently to VCP depletion and VCP-ATPase-deficiency.
In a successive study, Wojcik and colleagues systematically examined the consequences of VCP depletion applying a microarray analysis [118] . They identified 27 transcripts to be specifically upregulated upon RNAi of VCP [118] . Many of these transcripts code for proteins that are known to be upregulated upon ER stress and to be involved in the unfolded protein response, such as ATF3 (activation transcription factor 3) and BiP/GRP78 [118] . Five transcripts code for proteins participating in apoptosis, such as Harakiri, a pro-apoptotic protein that binds and inactivates the deathrepressor proteins Bcl-2 and Bcl-X L [118, 119] . Several transcripts code for proteins involved in oxidative stress response, such as cytosolic flavin reductase [118] . This suggests a role of oxidative stress during apoptotic cell death upon VCP depletion. If oxidative stress is a direct result of the observed ER stress or if it arises from other sources, such as mitochondria, remains an open question (Fig. 3A, no. 3, 4) . Oxidative stress modulates ATPase activity of VCP and therewith ERAD functionality and ER stress [116] (Fig. 3A , no. 5). In this context, it could play an important role in modulating apoptotic cell death due to VCP dysfunction [116] . Surprisingly, there are also studies that propose a proapoptotic role of functional VCP expressed at physiological levels [120, 121] (Fig. 3B) . In a proteomic screen to identify potential mediators of ER stress-triggered cell death, Rao and colleagues identified VCP to accumulate in caspase-activating microsomal extracts upon chemically-induced ER stress [121] . These authors could show that functional VCP was necessary for processing of caspase-9 in cell-free microsomal extracts under these conditions [121] . VCP depletion applying RNAi prohibited caspase-9 processing and activation and resulted in a reduction of chemically-induced ER stresstriggered cell death [121] . Because of the observed increased binding of VCP to caspase-9 and caspase-12 upon ER stress, the authors proposed that VCP might be part of a large protein complex necessary for caspase processing during ER stress-triggered apoptotic cell death [120, 121] (Fig. 3B) . These authors suggested the name "ERaptosome" for this VCP-containing ER-associated complex following the description of the mitochondria-associated "apoptosome" that is involved in caspase processing in mitochondria-dependent apoptotic pathways [120, 121] . Therefore, functional VCP may play a pro-apoptotic role during cell death triggered by exogenously applied ER stress [120, 121] .
This idea appears to contradict results where loss-of-function of VCP via depletion, mutation or oxidative modification causes ER stress and triggers cell death [36, 82, 105, 114, 117, 118 ] (see Fig. 3A ). An explanation may be the fact that Rao and colleagues did their experiments in cells lacking Apaf-1 [121] , and therefore these cells were unable to perform the "classical" mitochondria-dependent apoptotic pathway [121, 122] . However, a mitochondrial role during cell death upon VCP dysfunction, which could compete with the ERassociated cell death pathway that requires functional VCP, is currently unknown. Nonetheless, both dysfunctional VCP and functional VCP are able to cause apoptosis. Consequently, cells challenged with increased ER stress facilitating the ERassociated apoptotic pathway requiring functional VCP should benefit from VCP depletion (Fig. 3B) . In contrast, cells not exposed to ER stress would suffer from ER stress caused by the VCP depletion itself (see Fig. 3A ).
Proteins that misfold and aggregate within the ER, such as the cystic fibrosis-causing mutant chloride channel CFTR (cystic fibrosis transmembrane conductance regulator), cause ER stress [123, 124] . In a recent study in mammalian lung cell lines, ERAD inhibition via VCP depletion (RNAi) prevented mutant CFTR degradation and promoted its stabilization [123] . In mutant CFTR expressing cells, these authors were unable to see the induction of apoptosis upon depletion of VCP, and proposed RNAi of VCP as a therapeutical tool for rescuing functional mutant CFTR [123] . Relieve of mutant CFTRtriggered ER stress via VCP depletion possibly overcompensated the ER stress caused by the VCP depletion itself under these conditions.
Elevated cellular amounts of VCP may play an antiapoptotic role
The notion of an anti-apoptotic role of VCP, as originally described by Shirogane and colleagues [68] , was substantiated by the fact that increased levels of VCP strongly correlate with poor prognosis and metastasis of various human cancers, i.e., cells that are characterized by decreased ability to undergo apoptosis [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] . Nuclear factor kappa B (NFκB) is a transcription factor that upon stimulation translocates into the nucleus and triggers the expression of genes that promote cell proliferation and that protect cells against apoptosis [125] . VCP has been proposed to be critically involved in the dissociation and proteasomal degradation of the inhibitor of NFκB IκBα [126, 127] . Therefore, increased levels of VCP may result in decreased levels of IκBα and consequently in hyperactive NFκB signaling promoting cell proliferation (Fig.  4, no. 1-3) . In fact, Asai and colleagues identified VCP to be specifically upregulated in the subline LM8 of the murine osteosarcoma cell line Dunn [126] . LM8 had a higher metastatic potential and demonstrated, in contrast to the control Dunn cell line, a constitutive active expression of VCP [126] . Dunn cells overexpressing VCP mimicked the increased metastasis observed in LM8 cells and demonstrated decreased susceptibility to undergo apoptosis upon treatment of tumor necrosis factor α (TNFα) [126] . VCP overexpression was correlated with constantly activated NFκB, suggesting that high levels of VCP may indeed promote cell proliferation and cell survival through hyperactive NFκB signaling [126] .
The serine/threonine kinase Akt is another important mediator of cell survival and cell proliferation [128] . It promotes cell survival by indirectly activating NFκB signaling [129] . VCP has been recently shown to be a target of Akt signaling in neuronal cells and in MCF-7 breast cancer cells [130] [131] [132] . VCP interacted and co-localized with Akt upon Akt activation [130, 132] . Three serine residues in VCP were identified to be phosphorylated by Akt upon stimulation [130, 132] (Fig. 4, no. 1a) . Replacement of these serines with alanines resulted in a VCP triple mutant (S351/745/747A) that upon expression in breast cancer cells markedly decreased the Akt-mediated pro-survival effect of fibroblast growth factor 2 (FGF2) [132] . Strikingly, this VCP variant also inhibited the activation of NFκB by FGF2 [132] . Therefore, increased levels of VCP promote cell proliferation in providing a switch between the pro-survival pathways mediated by Akt and NFκB (Fig. 4) .
Two recent studies dealt with the question which factors regulate the expression of VCP in cancer cell lines [133, 134] . Qiu and colleagues and Zhang and colleagues identified the pre-B-cell leukemia transcription factor 1 (PBX1) and the E74-like factor 2, respectively, to bind in MCF7 mammary carcinoma cell line to the 5′ region of the VCP gene [133, 134] . Both transcription factors induced VCP expression [133, 134] (Fig. 4, no. 1b) . Since knock-down of these factors reduced both VCP levels and cell viability and increased the susceptibility of the cells to undergo apoptosis, these factors may play an important role in the regulation of VCP-mediated cell survival [133, 134] (Fig. 4) . 
Zebrafish
The zebrafish orthologue of Cdc48/VCP was originally identified to be a major cold-inducible protein in cold-treated fish [135] . The cellular amount of CDC48 increased during cold treatment over several days, but decreased markedly within one day after zebrafish cells (ZE cell line) were kept again in warm water [135] . Overexpression of CDC48 resulted in increased cell proliferation compared to the mock-transfected control, as measured by cell growth and increased DNA synthesis (BrdU assay) [66] . This effect was much more pronounced with cells kept at cold temperatures compared to cells grown in warm medium [66] . The observed increased cell proliferation was correlated with significantly decreased apoptotic cell death, as evidenced by reduced numbers of cells showing DNA fragmentation (TUNEL assay) [66] . Thus, CDC48 is a cold-inducible protein that shows an anti-apoptotic effect and promotes cell proliferation in zebrafish cells. The authors also analyzed the effect of expression of a mutant CDC48 with a tyrosine 805 to alanine replacement (Y805A) at the C-terminal site of the protein [66] (see Fig. 1 ). Expression of this mutant resulted in markedly decreased cell proliferation and significantly increased apoptotic cell death [66] . The tyrosine 805 residue is highly conserved and can also be found in mammalian VCP, in yeast Cdc48p, and in Xenopus p97/VCP [11, 66, 136] . This residue is a known phosphorylation site of mammalian VCP and yeast Cdc48p [11, [136] [137] [138] [139] . Specific phosphorylation and dephosphorylation of this residue via membrane-bound tyrosine kinases and tyrosine dephosphatases has been implicated in the regulation of the VCP-dependent assembly of the transitional ER in mammalian cells (membrane fusion) [136, 138, 139] and in the cell cycle dependent nuclear localization of yeast Cdc48p [11] . However, the role of the phosphorylation of this tyrosine residue in zebrafish cells remains to be elucidated. Nevertheless, the induction of apoptotic morphology in zebrafish cells expressing the CDC48 mutant lacking this important phosphorylation site suggests that dysfunction of Cdc48/VCP in membrane fusion and cell cycle processes might also sensitize cells to undergo programmed cell death. It would be of special interest if homologous mutations in yeast Cdc48p and mammalian VCP cause similar phenotypes and if the effects are different from the known apoptosis-triggering mutations in these species. These mutations locate in the second ATPase domain of Cdc48/VCP (e.g., cdc48
S565G and VCP-K524A), instead of the very carboxy-terminal site, and appear to affect predominantly ubiquitin-dependent processes and not membrane fusion and cell cycle functions of Cdc48/VCP [36, 56, 114] .
C. elegans
Using a yeast two-hybrid system to screen for interactors of CED-4, a central regulator of programmed cell death in C. elegans, Wu and colleagues identified the Cdc48/VCP homologue MAC-1 (member of the AAA family that bind CED-4) as a new potential interactor [69] . The interaction of MAC-1 to CED-4, and also to Apaf-1, the mammalian homologue of CED-4, was confirmed with immunoprecipitation studies [69] . MAC-1 also interacted with the nematode cell death regulators CED-3 and CED-9 when co-expressed in mammalian cells (293T cells) [69] . It is an essential protein, since depletion of this protein applying RNAi resulted in animals that arrest mostly in the second stage of larval development [69] . MAC-1 demonstrated to have an anti-apoptotic effect. Elevated expression of MAC-1 in a transgenic strain of C. elegans prevented cells to undergo programmed cell death [69] . Consistently, MAC-1 prevented CED-3 and CED-4 from causing apoptosis in mammalian cells (293T cells) [69] . Therefore, MAC-1 is a negative regulator of apoptosis in nematodes.
Although MAC-1 is a member of the AAA-ATPase family and resembles most to yeast Cdc48p and mouse VCP [69] , it remains an open question, whether MAC-1 is a functional homologue of Cdc48/VCP. Recently, two proteins have been identified in C. elegans with increased homology to Cdc48/ VCP and with typical Cdc48/VCP functionality, e.g., in ERAD [40, [140] [141] [142] [143] . It is currently unknown, whether these Cdc48/ VCP orthologues have similar roles in programmed cell death like MAC-1.
Drosophila
In a genetic screen, the Drosophila orthologue of Cdc48/ VCP ter94 has been identified as a dominant suppressor of the eye degeneration pathway triggered by targeted expression of human neurotoxic proteins comprising abnormally expanded polyglutamine stretches (ex-polyQ) [144] . In this Drosophila model for human polyglutamine disorders, flies harboring a hypomorphic allele of the ter94 gene beside a normal wild-type ter94 allele, i.e., flies expressing decreased amounts of ter94 protein, showed a drastically decreased degeneration of the Drosophila compound eye [144] . Drosophila containing two copies of the hypomorphic alleles of the ter94 gene, however, showed zygotic embryonic lethality, underlining the vital role of ter94 in Drosophila [144] . Comparison of different heterozygous loss-of-function mutations of ter94 demonstrated that increased loss-of-function of ter94 strongly correlated with decreased eye degeneration [144] . From these data, it was proposed that ter94 might be a positive effector in the polyQinduced cell death pathway. Consistent with this idea, expression of ter94 was upregulated in ex-polyQ-expressing cells before these cells started to die, and co-expression of ex-polyQ and ter94 severely enhanced the observed eye degeneration [144] . The pro-degeneration effect of ter94 was independent of the expression of ex-polyQ, because overexpression of ter94 in Drosophila eyes caused dose-dependently considerable degeneration of the eye due to massively increased apoptotic cell death, as evidenced by the increased numbers of cells showing DNA fragmentation [144] . Genetic analysis proved that ter94 did not act downstream of neither the known three major apoptosis-inducing genes in Drosophila, namely grim, reaper, and hid nor the nematode ced4 and human p53 pro-apoptotic genes [144] . Therefore, ter94 is a cell death effector by itself. From these data, the authors of this study proposed that the human ter94 homologue VCP may also be a pro-apoptotic effector in ex-polyQ-triggered cell death, and that decreasing the amount of VCP might be beneficial for cell survival [144] .
However, in no other species tested so far do increased levels of Cdc48/VCP cause apoptotic cell death. In contrast, mammalian VCP has been assigned to have an anti-apoptotic role in several studies [68, 126] . Decreased incidences of cell death and increased cell proliferation were also observed in zebrafish overexpressing the zebrafish orthologue CDC48 [66] . However, there is evidence that mammalian VCP may also be a direct mediator of ER stress-triggered apoptotic cell death [120, 121] (see Section 3.1.2 and Fig. 3B ). Here, VCP is necessary for caspase processing in ER-associated apoptotic cell death [120, 121] . Thus, there might be distinct apoptotic pathways that need functional Cdc48/VCP for being effective in killing the cells. In a context that favors such a proapoptotic role of Cdc48/VCP increased levels of this protein could be harmful for cell survival, as observed in Drosophila overexpressing ter94/VCP in the compound eye. A cellular context with such a pro-apoptotic role of Cdc48/VCP could be found in post-mitotic cells [144] . Indeed, ter94 and ex-polyQ were overexpressed in highly differentiated non-dividing cells (e.g., photoreceptor neurons) and triggered cell death in these very specialized cells. Many human neurodegenerative diseases are characterized by the loss of such specialized post-mitotic cells [144] . In contrast, the anti-apoptotic functions of Cdc48/VCP were described in less-specialized dividing cells, such as immortalized cancer cells [68, 126] .
Trypanosomes
TbVCP is the orthologue of Cdc48/VCP in African trypanosomes, protozoan parasites causative for sleeping sickness in humans [67] . Lamb and colleagues demonstrated that TbVCP is essential for trypanosome viability. Only one of the two homologous copies of the TbVCP gene could be disrupted without decreasing cell survival [67] . Constitutive overexpression of TbVCP with critical mutations in the D2 domain responsible for the major ATPase activity of this protein (see Fig. 1 ) failed due to the lethality of these TbVCP variants [67] . Consistent with the results observed in other species, regulated overexpression of these variants resulted in growth arrest (at all stages of the cell cycle) and cell death one day after triggering expression [67] . Cells expressing TbVCP mutants showed severe and characteristic morphological alterations [67] . Double mutants of TbVCP affecting both the D1 and the D2 domain of TbVCP resulted in a distinct phenotype in cells expressing these mutants [67] . Thus, in contrast to mammalian VCP, the D1 domain of TbVCP may be involved in the modulation of cell death in trypanosomes. TbVCP complemented and functionally replaced yeast Cdc48p despite of the great phylogenetic distance between trypanosomes and yeast [67] . Therefore, it might be of high interest if the morphological description of cell death in trypanosomes is based on similar mechanistic processes as observed in yeast.
Triple role of Cdc48/VCP in apoptosis
Cdc48/VCP is an essential protein, since knock-out of VCP results in early embryonic lethality or non-viable cells in numerous species, such as yeast [3, 56, 70] , mammalian cells [145] , Drosophila [144] , and trypanosomes [67] . Loss-ofATPase-activity of Cdc48/VCP has severe effects on cell survival and causes apoptotic cell death in all species tested so far, namely yeast [56] , mammalian cells [68] , and trypanosomes [67] . Therefore, the ATPase activity of Cdc48/VCP is, like the whole protein, essential for cell survival. The major ATPase activity of Cdc48/VCP is located in the second ATPase domain (D2) of this protein [5, 8] (see Fig. 1 ). Critical mutations in this domain drastically affect the ATPase activity of Cdc48/VCP [8, 114] . Cells expressing ATPase-deficient Cdc48/VCP demonstrate predominantly ERAD defects accompanied by ER stress and apoptotic cell death:
(i) Yeast cells expressing mutated CDC48 with a serine to glycine replacement within the D2 domain (cdc48 S565G ) demonstrate marked deficits in ERAD causing ER stress and ER expansion [56, 105] (Fig. 2, no. 1, 2) . The detrimental settings within the ER upon CDC48 mutation might affect mitochondria via increased association of ERderived microsomes to mitochondrial membranes [82, 105] (Fig. 2, no. 3 ). Nonetheless, a direct effect of CDC48 mutation on mitochondrial function cannot be excluded (Fig. 2, no. 4) . Consequently damaged mitochondria generate a burst of oxidative stress and trigger apoptotic cell death [82] (Fig. 2, no. 5, 8) . Overload of the ERresident oxidative protein folding machinery may contribute to the oxidative stress and may enforce mitochondrial impairment (Fig. 2, no. 6, 7) .
(ii) Mammalian cells expressing VCP with critical mutations within the D2 domain, especially VCP-K524A, also show pronounced ERAD impairment causing ER stress and the induction of the unfolded protein response [36, 114] (Fig.  3A , no. 1a, 2). Cells consequently die in an apoptotic fashion after the emergence of large cytoplasmic vacuoles that originate from abnormally expanded ER [36, 114] (Fig.  3A, no. 2, 6 ). These astonishingly similar phenotypes observed in yeast and mammalian cells suggest that mitochondria and oxidative stress may also play a role in apoptotic cell death in mammalian cells expressing ATPasedeficient VCP (Fig. 3A, no. 3, 4) . In mammalian cells but not in yeast, endogenous VCP can be reversibly oxidized leading to a decrease in its ATPase activity, resulting in ER stress [116] (Fig. 3A, no. 1b) . Regulation of VCP-ATPase activity might play an important role in modulating oxidative stress and ER stress. Therefore, in mammalian species, oxidative stress may amplify ERAD dysfunction and ER stress in a positive feedback loop (Fig. 3A , no. 5).
Depletion of VCP in mammalian cells results in dysfunction of VCP-dependent degradation of proteins [117, 118] (Fig. 3A, no. 1c) . Consistent with the results observed in cells expressing ATPase-deficient VCP, this leads in most cases to ER stress, unfolded protein response and apoptotic cell death [117, 118] (Fig. 3A, no. 2, 6 ). VCP depletion induces the expression of proteins involved in oxidative stress [118] , underlining a potential role of oxidative stress and mitochondria during apoptosis upon VCP dysfunction (Fig.  3A, no. 3, 4) .
In some cases, depletion of VCP prevents the cells from undergoing ER-associated apoptotic cell death triggered by sustained ER stress [121] (Fig. 3B, no. 1-3) . Functional VCP has been suggested to be an effector in such cell death scenarios [120, 121] . It plays an essential role in the processing and activation of caspases, resulting in cell death (Fig. 3B, no. 2, 3) . The cellular context may determine if depletion of VCP is beneficial or detrimental for cell survival.
Elevated cellular levels of Cdc48/VCP lead to increased cell proliferation in mammalian cells [68, 126] , correlated with increased incidence of cancer and metastasis [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] , and to increased cell proliferation in zebrafish [66] . In contrast, significantly (but not moderately) increased levels of ter94, the Drosophila orthologue of Cdc48/VCP, trigger apoptotic cell death in highly specialized and differentiated cells of the compound eye of the flies, suggesting a pro-apoptotic role of this protein at least under this very specialized context [144] . The anti-apoptotic role of elevated levels of mammalian VCP may be a result of the VCP-dependent activation of the prosurvival NFκB signaling [126, 127] that is further regulated by phosphorylation of specific serine residues of VCP by the anti-apoptotic kinase Akt [132] (Fig. 4) .
In summary, Cdc48/VCP affects apoptotic and antiapoptotic cellular processes in at least three different ways:
(i) Loss of Cdc48/VCP-ATPase activity due to mutation, oxidative modification or Cdc48/VCP depletion affects predominantly the Cdc48/VCP-dependent ERAD pathway, triggering ER stress, unfolded protein response, apoptotic cell death with possible pivotal roles of mitochondria and oxidative stress (see Figs. 2, 3A) . This seems to be the predominant Cdc48/VCP-dependent pathway and it is highly conserved from yeast to mammalian cells. (ii) Functional Cdc48/VCP is an essential pro-cell death effector molecule in specialized apoptotic cell death pathways, as observed in mammalian cells, in which cells die via an ER stress-triggered ER-associated apoptotic pathway (see Fig. 3B ), and in specialized eye cells in Drosophila. (iii) At elevated cellular levels, Cdc48/VCP can also increase the protection of cells against cellular stressors and apoptotic stimuli by stimulating the pro-survival NFκB pathway (see Fig. 4 ).
Cdc48/VCP therefore plays variant roles in cell survival and cell death that may manifest differently in various cell types, under different environmental conditions or in individual species. This complexity in the effect of Cdc48/ VCP on cell survival and cell death may be a mirror of its different cellular functions, indicating an integrative position of Cdc48/VCP in the adaptation to intracellular stress responses.
5. Cdc48/VCP-mediated apoptosis: implications to human disease
IBMPFD
Point mutations in the VCP gene have been described as causative for 'inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia' (IBMPFD), a rare human multisystem disorder [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . IBMPFD is characterized by adult-onset of proximal and distal muscle weakness, early onset of Paget's disease of bone, a metabolic bone disease that is characterized by overactive osteoclasts containing nuclear inclusions [146] , and premature frontotemporal dementia [147, 148] . Affected individuals suffer at least from one of these features. IBMPFD is inherited in an autosomal dominant fashion. In IBMPFD VCP was found in large or small rounded protein aggregates in affected scattered muscle fibers [34] or in neuronal nuclear inclusions comprising aggregated ubiquitinated proteins [35] . Therefore, it has been proposed that upon mutation dysfunction of VCP in its role in ubiquitin-dependent protein quality control might be causative for the disorder.
Most known mutations of VCP, comprising the most prevalent mutations, lie within the N-terminal domain but not in the conserved AAA-ATPase domains [31, 33, 34 ] (see Fig. 1 ). Recent data demonstrate that they do interfere neither with hexamerization of VCP nor with its ATPase activity [149] . Nonetheless, dysfunction of the ubiquitin-proteasome system and more specifically of ERAD has been observed in cells expressing these mutants, although the reasons for this dysfunction remain elusive [149] . The accumulation of polyubiquitinated aggregates and abnormally altered ER structure in these cells [149] suggest that ER stress is induced with potentially detrimental effects on cell survival (see Fig. 3A ), as observed in cells with ATPase-deficient Cdc48/VCP, e.g., yeast cells expressing mutated CDC48 (cdc48 S565G ) [56, 82, 105] . Increased cell loss due to the induction of apoptotic cell death may thus be one factor that results in the manifestation of the IBMPFD disease. However, since the IBMPFD-causing mutations do not affect the critical second ATPase domain (D2), additional factors, such as environmental factors, ageing, and genetic determinants may be needed for triggering apoptotic cell death. For instance, apolipoprotein E (APOE), a known genetic modifier of Alzheimer's disease, was recently identified to correlate with altered emergence of frontotemporal dementia in people suffering from IBMPFD [150] . A systematic analysis using various apoptotic cell models, such as yeast and mammalian cells, and the recently published transgenic mice expressing IBMPFD-causing VCP variants [151] may help to elucidate more critical factors and their roles during cell death in IBMPFD.
Protein deposition disorders
IBMPFD is a human disorder characterized by aberrant protein depositions. However, formation of protein aggregates, intranuclear or cytoplasmic inclusion bodies and extracellular plaques is a hallmark of many human degenerative disorders, especially in the pathogenesis of common neurodegenerative disorders such as Alzheimer's, Parkinson's, and Huntington's diseases [152] [153] [154] . Wild-type VCP colocalizes in situ with abnormal cellular protein aggregates and inclusions in motor neuron disease with dementia, in amyotrophic lateral sclerosis, in Creutzfeldt-Jacob, Alzheimer's, Parkinson's, Huntington's and Machado-Joseph diseases [36] [37] [38] . From these data, VCP has been proposed to be a sensor protein for aggregated proteins associated with human degenerative disorders [36, 37, 39] .
Huntington's and Machado-Joseph diseases both belong to a class of inherited neurodegenerative disorders characterized by the expansion of polyglutamine stretches (ex-polyQ) in those proteins responsible for each disorder. These expansions frequently lead to aggregation of these proteins [155] . In this context, VCP has been identified as an expolyQ interacting protein in vitro and in vivo [36] . In C. elegans the two identified VCP homologues modulate the aggregation of ex-polyQ proteins [40] . In mammalian cells VCP plays a dual role and is involved in both the clearance and formation of the abnormal protein aggregates caused by ex-polyQ proteins, and other aggregation-prone proteins [39, 41] .
The role of VCP during (apoptotic) neuronal cell loss underlining human polyglutamine disorders and other diseases characterized by abnormal protein aggregates remains elusive. A genetic screening of a Drosophila model for human polyglutamine diseases demonstrated the Drosophila homologue of VCP (ter94) as a pro-death effector during apoptotic cell death trigged by ex-polyQ proteins [144] . Loss-of-function of ter94 prevented ex-polyQ-caused cell death, whereas overexpression of ter94 enhanced the observed degeneration [144] . This single study suggests that the pro-apoptotic role of VCP might play a pivotal role during progression of polyglutamine disorders.
In contrast, accumulation of detrimental protein aggregates might result in VCP dysfunction [36, 114] (see Fig. 3A ). This may mimic a loss-of-function of VCP, eventually causing ER stress, unfolded protein response, aberrant ER expansion and apoptotic cell death [36, 114, 117, 118] . Indeed, VCP activity has been shown to be negatively regulated by oxidative modifications [116] , and oxidative stress is highly prevalent in protein deposition disorders [156] . This strongly suggests that loss-of-function of VCP may facilitate apoptotic cell death in these diseases. Therefore, apoptosis triggered by Cdc48/VCP depletion and Cdc48/VCP mutations may be an excellent model for the evaluation of cellular mechanisms underlying cell loss observed during pathogenesis of degenerative disorders characterized by aberrant protein depositions. Common features within many of these diseases are impairment of the ubiquitin-dependent protein degradation, ER stress, oxidative stress and a pathological involvement of mitochondria [152] [153] [154] 156, 157] . All these features were critically linked in apoptotic yeast cells expressing mutated CDC48 (cdc48 S565G ) [56, 71, 82, 105] . Therefore, a deeper analysis of apoptosis in this yeast model system in comparison to data obtained from mammalian model systems may give invaluable insights in the progression of these human degenerative disorders.
Cancer
Whereas at endogenous levels VCP is involved in human degenerative disorders, such as IBMPFD and protein deposition disorders, elevated levels of VCP have been linked to the promotion of cancer and increased incidence of metastasis [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] . In certain types of cancer tissues, e.g., colorectal carcinomas, pancreatic endocrine neoplasms, and follicular thyroid cancer, the expression level of VCP is markedly elevated and has been shown to associate with poor prognosis, proposing VCP expression levels as a useful marker for the progression of these cancers [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] .
VCP increases the protection of cells against apoptotic stimuli through activation of the NFκB signaling pathway [126, 127] (see Fig. 4 ). Specific transcription factors regulate VCP expression and therewith NFκB-mediated cell survival [133, 134] . The pro-survival Akt signaling pathway promotes the role of VCP in this process [132] (see Fig. 4 ). Targeted depletion of VCP in these cells might sensitize the cells to undergo apoptotic cell death due to cellular stress caused by VCP dysfunction and may interfere with aberrant cell proliferation and metastasis.
Conclusions
Cdc48/VCP is a highly conserved member of the AAAATPase family, involved in various cellular processes [20] [21] [22] [23] [24] [25] . Corresponding to its diverse cellular functions, it plays a role in different pathophysiological processes. Increased amounts of VCP are correlated with metastasis and cancer [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] . Upon mutation VCP causes IBMPFD disease [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , whereas wild-type VCP binds to aberrant protein aggregates characteristic for numerous human degenerative disorders and has been proposed to mediate cell loss in these diseases [36] [37] [38] . Applying different model organisms from yeast to mammalian cells, first insights in Cdc48/VCPmediated apoptotic processes were obtained. In a yeast model, mutation of CDC48 results in ERAD dysfunction, ER expansion and ER stress that is possibly propagated to mitochondria, causing these organelles to promote oxidative stress-dependent apoptotic cell death [5, 7, 56, 71, 82, 105] . Accordingly, similar mutations in mammalian VCP, as well as depletion of VCP, show very comparable results [36, 68, 114, 117, 118] . However, a critical role of mitochondria in these cases has not yet been evaluated. This VCP-mediated apoptotic scenario may be most relevant for cell loss in IBMPFD disease and protein deposition disorders. Beside the induction of apoptosis via loss-of-function of Cdc48/VCP upon depletion or mutation, functional Cdc48/VCP plays an additional pro-apoptotic role [120, 121, 144] . This may be important for specialized cells that are challenged by exogenously applied ER stress [120] [121] [122] . VCP also protects cells against apoptotic insults via activation of the NFκB signaling pathway [126, 132] . This could be relevant for VCPmediated promotion of metastasis and cancer [126, 132] . Therefore, Cdc48/VCP-mediated apoptotic processes are complex, since Cdc48/VCP plays a triple role: (i) induction of apoptosis upon loss-of-function of the protein, (ii) pro-apoptotic effector role of endogenous protein, and (iii) anti-apoptotic role of VCP at elevated protein levels. Elucidation of the interplay of these three roles of Cdc48/VCP in cell death and cell survival and the relevance of the individual pathways for human disorders remains an elaborate task for the future.
